1. Home
  2. UG vs IGC Comparison

UG vs IGC Comparison

Compare UG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.68

Market Cap

30.2M

ML Signal

N/A

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.28

Market Cap

28.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
IGC
Founded
1942
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
28.5M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
UG
IGC
Price
$6.68
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
3.4K
263.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
7.63%
N/A
EPS Growth
N/A
59.09
EPS
0.20
N/A
Revenue
$12,181,971.00
$1,271,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$15.12
P/E Ratio
$32.75
N/A
Revenue Growth
11.91
N/A
52 Week Low
$5.58
$0.24
52 Week High
$10.09
$0.50

Technical Indicators

Market Signals
Indicator
UG
IGC
Relative Strength Index (RSI) 46.93 49.74
Support Level $6.31 N/A
Resistance Level $6.75 $0.32
Average True Range (ATR) 0.15 0.02
MACD -0.01 0.00
Stochastic Oscillator 40.00 27.27

Price Performance

Historical Comparison
UG
IGC

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: